Global Osteosynthesis Devices Market

Osteosynthesis Devices Market Size, Share, Growth Analysis, By Type(Internal Devices, Screws & Plates, Wires & pins, Intramedullary rods and nails), By Material(Degradable, Nondegradable), By Fracture(Skull, Facial bones, Sternum or one or more ribs, or both), By Region - Industry Forecast 2024-2031


Report ID: SQMIG20C2063 | Region: Global | Published Date: February, 2024
Pages: 157 | Tables: 112 | Figures: 76

Osteosynthesis Devices Market Competitive Landscape

The fierce competition in the global osteosynthesis devices market is characterized by major competitors competing to gain market share through cutting-edge products and calculated business tactics. Industry giants such as Stryker Corporation, DePuy Synthes (a Johnson & Johnson subsidiary), Zimmer Biomet Holdings, and Smith & Nephew, among others, compete for supremacy by utilizing their well-known brand reputations, extensive product portfolios, and international distribution networks. These key players continuously invest in research and development to introduce cutting-edge osteosynthesis solutions that cater to evolving patient needs.

Strategic mergers, acquisitions, and partnerships remain prominent trends in this landscape. These endeavors allow companies to expand their product offerings, access new markets, and enhance their technological capabilities. Moreover, collaborations with healthcare institutions and research organizations aid in product development, clinical trials, and market penetration. The shift towards customized medicine and patient-specific solutions is boosting the adoption of advanced technology, further intensifying competition among enterprises attempting to provide individualized therapies.

Top Player’s Company Profiles

  • Stryker (United States)
  • Exactech (United States)
  • FH Orthopedics (United States)
  • Globus Medical (United States)
  • RTI Surgical (United States)
  • NuVasive (United States)
  • MIS Implants Technologies (Switzerland)
  • Ortho Solutions (United States)
  • DePuy Synthes (United States)
  • Smith & Nephew (United Kingdom)
  • Alphatec Spine (United States)
  • Zimmer Biomet (United States)
  • Orthofix International (United States)
  • B. Braun Melsungen AG (Germany)
  • Aap Implantate (Germany)
  • Wright Medical Group (United States)
  • Bioventus (United States)

$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Osteosynthesis Devices Market size was valued at USD 9.23 billion in 2022 and is poised to grow from USD 9.97 billion in 2023 to USD 18.45 billion by 2031, growing at a CAGR of 8% in the forecast period (2024-2031).

The fierce competition in the osteosynthesis devices market is characterized by major competitors competing to gain market share through cutting-edge products and calculated business tactics. Industry giants such as Stryker Corporation, DePuy Synthes (a Johnson & Johnson subsidiary), Zimmer Biomet Holdings, and Smith & Nephew, among others, compete for supremacy by utilizing their well-known brand reputations, extensive product portfolios, and international distribution networks. These key players continuously invest in research and development to introduce cutting-edge osteosynthesis solutions that cater to evolving patient needs. 'Stryker (United States)', 'Exactech (United States)', 'Medtronic (Ireland)', 'JRI Orthopaedics (United States)', 'FH Orthopedics (United States)', 'Globus Medical (United States)', 'RTI Surgical (United States)', 'NuVasive (United States)', 'MIS Implants Technologies (Switzerland)', 'KLS Martin (Germany)', 'Ortho Solutions (United States)', 'DePuy Synthes (United States)', 'Smith & Nephew (United Kingdom)', 'Alphatec Spine (United States)', 'Zimmer Biomet (United States)', 'Orthofix International (United States)', 'B. Braun Melsungen AG (Germany)', 'Aap Implantate (Germany)', 'Wright Medical Group (United States)', 'Bioventus (United States)'

The aging population is a significant driver, as elderly individuals are more prone to fractures and orthopedic issues. The rising prevalence of osteoporosis and age-related conditions fuels the demand for osteosynthesis devices.

Personalized Medicine: The demand for customized implants and patient-specific therapies is rising. As a result of breakthroughs in imaging technology and 3D printing, it is now possible to produce patient-specific osteosynthesis devices that are compatible with each patient's anatomy which improves the results after the treatment.

As of 2022, North America held the dominant position in the osteosynthesis devices market, holding the largest market share at 52.6% of the revenue. The region’s market supremacy can be credited to a number of factors that have changed the terrain of the orthopedic scene. Noteworthy among these factors are the concerted efforts of governments, the continuous release of new products, and robust investments in research and development. The buoyant healthcare expenditure within the region further propels its leadership status. Notably, the United States stands as a pivotal driver within North America due to its remarkable concentration of the major orthopedic device market. This concentration, predominantly in the U.S., positions it as not only the most financially rewarding but also the largest market for osteosynthesis equipment, securing a staggering 90% or more of the market share in the region.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

Global Osteosynthesis Devices Market

Report ID: SQMIG20C2063

$5,300
BUY NOW GET FREE SAMPLE